ES2073847T3 - Derivados del 2,3,3a,4,5,9b-hexahidro-1h-benzo(e)indol. - Google Patents
Derivados del 2,3,3a,4,5,9b-hexahidro-1h-benzo(e)indol.Info
- Publication number
- ES2073847T3 ES2073847T3 ES92120925T ES92120925T ES2073847T3 ES 2073847 T3 ES2073847 T3 ES 2073847T3 ES 92120925 T ES92120925 T ES 92120925T ES 92120925 T ES92120925 T ES 92120925T ES 2073847 T3 ES2073847 T3 ES 2073847T3
- Authority
- ES
- Spain
- Prior art keywords
- precipitado
- rent
- precipitated
- derivatives
- cis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Lifetime
Links
- SIKJAQJRHWYJAI-UHFFFAOYSA-N Indole Chemical compound C1=CC=C2NC=CC2=C1 SIKJAQJRHWYJAI-UHFFFAOYSA-N 0.000 title 1
- -1 AMINO Chemical class 0.000 abstract 2
- 208000024827 Alzheimer disease Diseases 0.000 abstract 2
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical class [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 206010039966 Senile dementia Diseases 0.000 abstract 1
- 239000002253 acid Substances 0.000 abstract 1
- 230000001149 cognitive effect Effects 0.000 abstract 1
- 229910052739 hydrogen Inorganic materials 0.000 abstract 1
- 239000001257 hydrogen Substances 0.000 abstract 1
- 230000006993 memory improvement Effects 0.000 abstract 1
- 239000000203 mixture Substances 0.000 abstract 1
- 238000011321 prophylaxis Methods 0.000 abstract 1
- 238000011282 treatment Methods 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/58—[b]- or [c]-condensed
- C07D209/60—Naphtho [b] pyrroles; Hydrogenated naphtho [b] pyrroles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
Landscapes
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Neurosurgery (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Hospice & Palliative Care (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Psychiatry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Indole Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Abstract
DERIVADOS CIS NDOL DE LA FORMULA GENERAL I DONDE R1 SIGNIFICA UN RESTO DE LA FORMULA IL PRECIPITADO O ALQUIL PRECIPITADO SUSTITUIDO A TRAVES DE CICLOALQUIL PRECIPITADO, ARIL, AROIL, AROILAMINO, AMINO O A TRAVES DE UN GRUPO AMINO CICLICO, AMIDO O IMIDO, R3 ES HIDROGENO O ALQUIL PRECIPITADO, R4 ALQUIL PRECIPITADO Y R5 HIDROGENO O ALQUIL PRECIPITADO, MEZCLAS CORRESPONDIENTES TRANSISOMERO O CIS-TRANS-ISOMEROS Y SALES DE ADICION ACIDA UTILIZABLES FARMACEUTICAMENTE SON NUEVAS Y SE CARACTERIZAN A TRAVES DE PROPIEDADES TERAPEUTICAS COMPLETAS. SON APROPIADAS ESPECIALMENTE PARA EL TRATAMIENTO Y PROFILAXIS DE PERTURBACIONES COGNITIVAS Y DEMENCIA SENIL (ESPECIALMENTE ENFERMEDAD DE ALZHEIMER) Y PARA LA MEJORA DE LA CAPACIDAD DE MEMORIA.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CH380691 | 1991-12-20 | ||
| CH325492 | 1992-10-19 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ES2073847T3 true ES2073847T3 (es) | 1995-08-16 |
Family
ID=25692569
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ES92120925T Expired - Lifetime ES2073847T3 (es) | 1991-12-20 | 1992-12-09 | Derivados del 2,3,3a,4,5,9b-hexahidro-1h-benzo(e)indol. |
Country Status (21)
| Country | Link |
|---|---|
| US (2) | US5318966A (es) |
| EP (1) | EP0548664B1 (es) |
| JP (1) | JPH07119215B2 (es) |
| CN (1) | CN1037510C (es) |
| AT (1) | ATE123277T1 (es) |
| AU (1) | AU661076B2 (es) |
| BG (1) | BG61186B1 (es) |
| CA (1) | CA2084442A1 (es) |
| CZ (1) | CZ381092A3 (es) |
| DE (1) | DE59202406D1 (es) |
| DK (1) | DK0548664T3 (es) |
| ES (1) | ES2073847T3 (es) |
| FI (1) | FI925774A (es) |
| GR (1) | GR3017256T3 (es) |
| HU (2) | HU9203956D0 (es) |
| IL (1) | IL104080A (es) |
| IS (1) | IS3961A (es) |
| MY (1) | MY108026A (es) |
| NO (1) | NO179325C (es) |
| NZ (1) | NZ245463A (es) |
| TW (1) | TW239127B (es) |
Families Citing this family (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5486611A (en) * | 1989-07-13 | 1996-01-23 | The Upjohn Company | Carboxamido-(1,2N)-carbocyclic-2-aminotetralin derivatives |
| WO1991000856A2 (en) * | 1989-07-13 | 1991-01-24 | The Upjohn Company | (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
| ES2130135T3 (es) * | 1990-01-11 | 1999-07-01 | Upjohn Co | Nuevos compuestos heterociclicos de 6,7,8,9-tetrahidro-3h-benz(e)indol con actividad terapeutica sobre el sistema nervioso central. |
| US5434170A (en) * | 1993-12-23 | 1995-07-18 | Andrulis Pharmaceuticals Corp. | Method for treating neurocognitive disorders |
| WO1996003377A1 (en) * | 1994-07-27 | 1996-02-08 | Sankyo Company, Limited | Heterocyclic compounds, useful as allosteric effectors at muscarinic receptors |
| US5859295A (en) * | 1994-12-05 | 1999-01-12 | University Of Kentucky Research Foundation | Canavanine analogs and their use as chemotherapeutic agents |
| US5889006A (en) * | 1995-02-23 | 1999-03-30 | Schering Corporation | Muscarinic antagonists |
| IL117149A0 (en) * | 1995-02-23 | 1996-06-18 | Schering Corp | Muscarinic antagonists |
| GB9612153D0 (en) * | 1996-06-11 | 1996-08-14 | Smithkline Beecham Plc | Compounds |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB1277789A (en) * | 1969-09-08 | 1972-06-14 | Logeais Labor Jacques | Improvements in or relating to new polycyclic pyrrole derivatives |
| JPS4930836B1 (es) * | 1971-07-22 | 1974-08-16 | ||
| JPS4916862A (es) * | 1972-06-14 | 1974-02-14 | ||
| SE8004002L (sv) * | 1980-05-29 | 1981-11-30 | Arvidsson Folke Lars Erik | Terapeutiskt anvendbara tetralinderivat |
| SE8302361D0 (sv) * | 1983-04-27 | 1983-04-27 | Astra Laekemedel Ab | New tricyclic amines |
| JP2785879B2 (ja) * | 1989-05-31 | 1998-08-13 | ジ・アップジョン・カンパニー | 治療学的に有用な２―アミノテトラリン誘導体 |
| WO1991000856A2 (en) * | 1989-07-13 | 1991-01-24 | The Upjohn Company | (1,2n) and (3,2n)-carbocyclic-2-amino tetralin derivatives |
-
1992
- 1992-11-27 TW TW081109528A patent/TW239127B/zh active
- 1992-12-03 CA CA002084442A patent/CA2084442A1/en not_active Abandoned
- 1992-12-09 AT AT92120925T patent/ATE123277T1/de active
- 1992-12-09 DK DK92120925.0T patent/DK0548664T3/da active
- 1992-12-09 ES ES92120925T patent/ES2073847T3/es not_active Expired - Lifetime
- 1992-12-09 EP EP92120925A patent/EP0548664B1/de not_active Expired - Lifetime
- 1992-12-09 DE DE59202406T patent/DE59202406D1/de not_active Expired - Fee Related
- 1992-12-14 NO NO924829A patent/NO179325C/no unknown
- 1992-12-14 HU HU9203956A patent/HU9203956D0/hu unknown
- 1992-12-14 HU HU9203956A patent/HUT68178A/hu unknown
- 1992-12-14 IL IL104080A patent/IL104080A/xx not_active IP Right Cessation
- 1992-12-14 NZ NZ245463A patent/NZ245463A/en unknown
- 1992-12-15 AU AU30186/92A patent/AU661076B2/en not_active Ceased
- 1992-12-18 BG BG97201A patent/BG61186B1/bg unknown
- 1992-12-18 IS IS3961A patent/IS3961A/is unknown
- 1992-12-18 MY MYPI92002338A patent/MY108026A/en unknown
- 1992-12-18 FI FI925774A patent/FI925774A/fi not_active Application Discontinuation
- 1992-12-19 CN CN92114640A patent/CN1037510C/zh not_active Expired - Fee Related
- 1992-12-21 JP JP4355382A patent/JPH07119215B2/ja not_active Expired - Lifetime
- 1992-12-21 CZ CS923810A patent/CZ381092A3/cs unknown
-
1993
- 1993-07-16 US US08/093,412 patent/US5318966A/en not_active Expired - Fee Related
- 1993-09-03 US US08/118,831 patent/US5318967A/en not_active Expired - Fee Related
-
1995
- 1995-08-30 GR GR950402372T patent/GR3017256T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CN1088576A (zh) | 1994-06-29 |
| DK0548664T3 (da) | 1995-09-04 |
| NO179325C (no) | 1996-09-18 |
| JPH07119215B2 (ja) | 1995-12-20 |
| NZ245463A (en) | 1995-05-26 |
| CN1037510C (zh) | 1998-02-25 |
| CZ381092A3 (en) | 1993-09-15 |
| HUT68178A (en) | 1995-05-29 |
| AU661076B2 (en) | 1995-07-13 |
| FI925774A0 (fi) | 1992-12-18 |
| US5318967A (en) | 1994-06-07 |
| HU9203956D0 (en) | 1993-03-29 |
| EP0548664B1 (de) | 1995-05-31 |
| EP0548664A1 (de) | 1993-06-30 |
| AU3018692A (en) | 1993-06-24 |
| NO924829L (no) | 1993-06-21 |
| CA2084442A1 (en) | 1993-06-21 |
| IL104080A0 (en) | 1993-05-13 |
| DE59202406D1 (de) | 1995-07-06 |
| GR3017256T3 (en) | 1995-11-30 |
| IL104080A (en) | 1997-04-15 |
| ATE123277T1 (de) | 1995-06-15 |
| US5318966A (en) | 1994-06-07 |
| NO179325B (no) | 1996-06-10 |
| BG97201A (bg) | 1993-12-24 |
| JPH06128228A (ja) | 1994-05-10 |
| NO924829D0 (no) | 1992-12-14 |
| MY108026A (en) | 1996-07-30 |
| BG61186B1 (bg) | 1997-02-28 |
| IS3961A (is) | 1993-06-21 |
| TW239127B (es) | 1995-01-21 |
| FI925774A (fi) | 1993-06-21 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE162521T1 (de) | 3-aminopiperidine derivate und verwandete stickstoff enthaltende heterocyclische verbindungen | |
| MX9206499A (es) | Derivados de etilendiamina aciclica | |
| KR0179054B1 (en) | Heterocyclic-cyclic amine derivatives | |
| FI915920A0 (fi) | Serotoninantagonister. | |
| TW270116B (es) | ||
| DK0655996T3 (da) | Substituerede benzylamino-nitrogenholdige, ikke-aromatiske, heterocykliske forbindelser | |
| MY107157A (en) | Quinuclidine derivatives. | |
| MX9203018A (es) | Fluoroalcoxibencilamino-derivados de heterociclos nitrogenados. | |
| CA2104909A1 (en) | Decahydroisoquinolines as excitatory amino acid receptor antagonists | |
| DE69728768D1 (de) | 2,4-diaminopyrimidine derivates als dopamine d4 rezeptorantagonisten | |
| ES2073847T3 (es) | Derivados del 2,3,3a,4,5,9b-hexahidro-1h-benzo(e)indol. | |
| CO4410330A1 (es) | Nuevos derivados de bencimidazol farmacologicamente activos y sus sales de adicion acida | |
| SE9504618D0 (sv) | New Compounds | |
| DK0628039T3 (da) | 2,3,4,5-tetrahydro-1H-benzazepiner og farmaceutisk acceptable syreadditionssalte deraf. | |
| YU9893A (sr) | Derivati indola | |
| RU92016278A (ru) | Производные индола |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| FG2A | Definitive protection |
Ref document number: 548664 Country of ref document: ES |